News
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...
All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...
The FDA regulates products that account for one-fifth of American consumer spending—everything from lettuce to vapes to pet ...
FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been ...
FDA Commissioner Marty Makary said that one of his key priorities is to modernize the agency by streamlining the drug review ...
1d
Pharmaceutical Technology on MSNFDA Commissioner envisions fewer delays, more clinical trial flexibility and AI useFDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.
1d
The Mirror US on MSNFDA to fast-track drug approvals for companies pushing ‘national priorities’ in major overhaulFood and Drug Administration Commissioner Marty Makary announced that the agency intends to fast-track reviews for certain ...
Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory ...
Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
The Food and Drug Administration announced the launch of a new program to fast-track agency approvals for drug manufacturers ...
16h
Tampa Free Press on MSNDNA Danger Zone: FDA Halts Controversial Trials Exporting American Cells To Hostile NationsThe U.S. Food and Drug Administration (FDA) today announced an immediate halt to new clinical trials that were shipping ...
According to an internal email, the agency may be in for more consolidation in areas including human resources, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results